Investing Ideas
/
Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth

Bangladeshi Pharmaceuticals & Biotech Undervalued based on future growth

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Beximco Pharmaceuticals

Market Cap: ৳49.7b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

BXPHARMA

৳111.50

-4.5%

35.2%